Skip to main content
Clinical Trials/NCT00915304
NCT00915304CompletedPhase 1

Patient Specific Automatic Reminders in Primary Care - the EBMeDS Randomised Trial

Tampere University2 sites in 1 country12,101 target enrollmentStarted: June 1, 2009Last updated:
Conditions

Trial Snapshot

Phase
Phase 1
Status
Completed
Enrollment
12,101
Locations
2
Primary Endpoint
The number of reminders triggered (in relation to the number of eligible patients, Ri/Ni) during repeated Virtual Health Checks (VHCs)

Study Overview

Brief Summary

The purpose of this study is to analyze the effect of the Evidence-Based Medicine electronic Decision Support (EBMeDS) automatic reminders in primary health care.

Hypothesis (1)is that in the intervention group the total number of EBMeDS reminders will decrease compared to the control group.

Hypothesis (2) is that in the intervention group the quality measures will increase faster compared to the control group at follow-up time.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Single Group
Primary Purpose
Health Services Research
Masking
Double (Participant, Investigator)

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • All residents of Sipoo who have patient ID number in the Mediatri electronic patient record system in Sipoo Health Centre

Exclusion Criteria

  • Those residents who's occupational health care is produced by Sipoo Health Centre

Outcomes

Primary Outcomes

The number of reminders triggered (in relation to the number of eligible patients, Ri/Ni) during repeated Virtual Health Checks (VHCs)

Time Frame: Follow-up time max one and half year

VHC will be performed once a week for the whole study population, beginning at baseline and before randomisation. The main outcome measure is Ri/Ni at follow-up time after commencement of the study where Ri is the total number of reminders triggered by the patient record data in intervention and in control group at the time of analysis, and Ni is the total number of patients.

Secondary Outcomes

  • Specific clinical measures compared to an intervention and a control group

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Tiina Kortteisto

researcher

Tampere University

Study Sites (2)

Loading locations...

Similar Trials